Literature DB >> 3548452

Simultaneous use of Plasmodium falciparum crude antigen and red blood cell control antigen in the enzyme-linked immunosorbent assay for malaria.

P Demedts, C Vermeulen-Van Overmeir, M Wery.   

Abstract

An enzyme-linked immunosorbent assay for malaria, based upon duplicate testing of serum samples on both a crude Plasmodium falciparum antigen and a red blood cell control antigen, is evaluated. Results were analyzed using the Student's t-test for identification of positive serum samples (t greater than or equal to 2.92, P less than or equal to 0.05) and for calculation of the mean difference in absorbance values (delta ABS) obtained between the P. falciparum wells and the control wells. Cross-evaluation with the IFA test for P. falciparum antibodies gave 89.6% concording positive or negative results. Among discrepant sera 8.35% were ELISA+/IFA- and 2.05% ELISA-/IFA+. In addition, delta ABS values in ELISA were highly correlated to titers obtained in immunofluorescence (r = 0.80, P less than 0.001). The results confirm the high degree of species-specificity of the ELISA using P. falciparum crude antigen. The necessity of the simultaneous use of red blood cell control antigen with a crude plasmodial antigen is demonstrated by comparing the presented results with those obtained on the P. falciparum antigen only.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3548452     DOI: 10.4269/ajtmh.1987.36.257

Source DB:  PubMed          Journal:  Am J Trop Med Hyg        ISSN: 0002-9637            Impact factor:   2.345


  3 in total

1.  Western blot diagnosis of vivax malaria with multiple stage-specific antigens of the parasite.

Authors:  E S Son; T S Kim; H W Nam
Journal:  Korean J Parasitol       Date:  2001-06       Impact factor: 1.341

2.  Filariasis and malaria sera from Orissa (India) lack human immunodeficiency virus (HIV) antibody reactivity.

Authors:  V R Subramanyam
Journal:  World J Microbiol Biotechnol       Date:  1991-05       Impact factor: 3.312

3.  ELISA detection of vivax malaria with recombinant multiple stage-specific antigens and its application to survey of residents in endemic areas.

Authors:  Sera Kim; Hye-Jin Ahn; Tong-Soo Kim; Ho-Woo Nam
Journal:  Korean J Parasitol       Date:  2003-12       Impact factor: 1.341

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.